Under the agreement, Covidien will purchase all of the outstanding capital stock of Barrx with additional future earn-out payments made upon achievement of certain milestones.
Covidien Surgical Solutions Group President Bryan Hanson said they look forward to accelerate the growth and expand the Halo ablation technology product line.
Barrx Medical president and CEO Greg Barrett said Covidien provides many advantages to Barrx Medical that support their mission in long-term growth and value to patients.
"Together we’ll be able to leverage our core strengths to improve and develop new RF technologies," BaBarrx Medical rrett said.
